Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 7/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.35 |
| ▸ | CPB1 | P15086 | 1/20 | 0.35 |
| ▸ | CTSC | P53634 | 2/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1666820 | 0.99 | SLC15A2 (0.42) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL483799 | 0.99 | SLC15A2 (0.42) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| Hydrochloric Acid SCHEMBL2199717 | 0.97 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL2811067 | 0.97 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| Hydrochloric Acid SCHEMBL1436163 | 0.97 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL30954680 | 0.97 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL29590566 | 0.93 | SLC15A2 (0.49) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL20783813 | 0.93 | SLC15A2 (0.49) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL31453803 | 0.93 | SLC15A2 (0.49) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL29888249 | 0.90 | SLC15A2 (0.44) | SLC15A2ITGB3ITGA2BCPB2CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255032-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | PROCYTE CORPORATION (US) | 2008-10-16 | — | — | US | disclosed |
| US-7384916-B2 | Methods and compositions for preventing and treating aging or photodamaged skin | PROCYTE CORPORATION (US) | 2008-06-10 | — | — | US | disclosed |
| EP-1765280-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING HYPERPIGMENTATION OF SKIN | PROCYTE CORPORATION (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20060246029-A1 | Methods and compositions for preventing and treating aging or photodamaged skin | PROCYTE CORPORATION (US) | 2006-11-02 | — | — | US | disclosed |
| US-20060018851-A1 | Methods and compositions for preventing and treating hyperpigmentation of skin | PROCYTE CORPORATION (US) | 2006-01-26 | — | — | US | disclosed |
| WO-2006004787-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING HYPERPIGMENTATION OF SKIN | PROCYTE CORPORATION (US) | 2006-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246029-A1 | Methods and compositions for preventing and treating aging or photodamaged skin | RBP1, RBP4, SOD1 | SLC15A2 2656/4885ITGB3 2875/4885ITGA2B 2979/4885 |
| US-20060018851-A1 | Methods and compositions for preventing and treating hyperpigmentation of skin | RBP1, RBP4, MC1R | SLC15A2 1582/4885ITGB3 3184/4885ITGA2B 3154/4885 |
| US-20080255032-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | RBP1, RBP4, SOD1 | SLC15A2 2656/4885ITGB3 2875/4885ITGA2B 2979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.